Estimating the economic consequences of an increased medication adherence due to a potential improvement in the inhaler technique with Spiromax compared with Turbuhaler in patients with moderate-to-severe chronic obstructive pulmonary disease in Spain

Vista senzilla d'ítem
dc.contributor.authorDarbà, Josep
dc.contributor.authorRamírez, Gabriela
dc.contributor.authorGarcía-Rivero, Juan L.
dc.contributor.authorMayoralas, Sagrario
dc.contributor.authorPascual, José Francisco
dc.contributor.authorVargas, Diego
dc.contributor.authorBijedic, Adi
dc.date.accessioned2017-03-02T15:15:56Z
dc.date.available2017-03-02T15:15:56Z
dc.date.issued2017-02
dc.date.updated2017-03-02T15:15:56Z
dc.description.abstractThe objective of this study was to estimate the economic impact of the introduction of DuoResp® Spiromax®, budesonide/formoterol fixed-dose combination (FDC), focusing on an increase in medication adherence due to an enhancement of the inhalation technique for the treatment of COPD patients in Spain and 5 regions including Andalusia, Catalonia, Galicia, Madrid, and Valencia. ...
dc.format.extent11 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec668396
dc.identifier.issn1178-6981
dc.identifier.pmid28228660
dc.identifier.urihttps://hdl.handle.net/2445/107750
dc.language.isoeng
dc.publisherDove Medical Press
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.2147/CEOR.S125301
dc.relation.ispartofClinicoeconomics and Outcomes Research, 2017, vol. 9, num. February, p. 127-137
dc.relation.urihttps://doi.org/10.2147/CEOR.S125301
dc.rightscc-by-nc (c) Darbà, Josep et al., 2017
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/es
dc.sourceArticles publicats en revistes (Economia)
dc.subject.classificationAdministració de medicaments
dc.subject.classificationMalalties pulmonars obstructives cròniques
dc.subject.classificationTractament tèrmic
dc.subject.classificationEconomia de la salut
dc.subject.otherAdministration of drugs
dc.subject.otherChronic obstructive pulmonary diseases
dc.subject.otherHeat treatment
dc.subject.otherMedical economics
dc.titleEstimating the economic consequences of an increased medication adherence due to a potential improvement in the inhaler technique with Spiromax compared with Turbuhaler in patients with moderate-to-severe chronic obstructive pulmonary disease in Spain
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Miniatura
Nom:
668396.pdf
Mida:
204.4 KB
Format:
Adobe Portable Document Format
Descarregar

Col·leccions

Articles publicats en revistes (Economia)